LIEN

Business Context and Reporting Period

Company: Chicago Atlantic BDC, Inc. (Ticker: LIEN)
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Quarter ended March 31, 2025
Business Overview: An externally managed, closed-end business development company (BDC) and regulated investment company (RIC) focused on investing in highly complex and regulated industries, primarily the cannabis ecosystem. The company invests in secured debt, unsecured debt, equity warrants, and direct equity in privately held businesses.

Key Financial Metrics

Material Changes vs. Prior Period

• Portfolio Expansion: Investment income surged from $2.8 million to $11.9 million, and net investment income turned positive ($7.6 million) compared to a loss of $0.1 million in Q1 2024. This growth is primarily attributable to the October 2024 Loan Portfolio Acquisition, which increased the amortized cost of the investment portfolio by approximately $234.8 million.
• Expense Structure: Total operating expenses increased to $5.2 million from $2.8 million. This includes the recognition of income-based incentive fees ($1.9 million) and management fees ($1.3 million) which were negligible or non-existent in the prior year due to the smaller asset base. However, the Adviser waived $658,477 in G&A expenses and applied a $316,000 expense limitation credit.
• Cash Flow: Net cash used in operating activities was $7.3 million, driven by $20.6 million in investment purchases and $0.6 million in PIK interest capitalized, partially offset by $7.6 million in proceeds from sales and repayments. Cash balances decreased from $23.9 million to $14.9 million.
• Unrealized Gains/Losses: The portfolio experienced a net unrealized depreciation of $34,064, contrasting with a net unrealized appreciation of $599,620 in Q1 2024.

Guidance, Outlook, Risks, and Unusual Items

• Capital Resources: On February 11, 2025, the company entered into a $100 million senior secured revolving credit facility with Western Alliance Bank. As of March 31, 2025, there were no borrowings outstanding, providing significant liquidity for future investments.
• Dividends: The Board declared a quarterly dividend of $0.34 per share for Q1 2025 (paid April 11, 2025). A subsequent dividend of $0.34 per share was approved on May 12, 2025, payable July 11, 2025.
• Management Changes: Significant leadership changes occurred in Q1 2025. Dr. Andreas Bodmeier resigned as CEO, replaced by Peter Sack. Mr. Mahajan resigned as CFO, replaced by Martin Rodgers. Two directors also resigned and were replaced.
• Risk Factors: The company highlights concentration risk, with 79.2% of the portfolio invested in the cannabis industry. Risks include federal enforcement actions, regulatory changes, and the speculative nature of the cannabis sector. Additionally, 100% of the portfolio is classified as Level 3 assets, requiring significant unobservable inputs for valuation.
• Unusual Items: Transaction expenses related to the Loan Portfolio Acquisition were $2.1 million in Q1 2024 but $0 in Q1 2025, as the acquisition closed in October 2024.

Investor Verification Checklist

• Portfolio Concentration: Verify the impact of the 79.2% concentration in the cannabis sector on credit risk and valuation stability.
• Expense Waivers: Confirm the duration and terms of the expense limitation agreement and G&A waivers, which significantly reduced the net expense ratio to 1.42%.
• Valuation Methodology: Review the Level 3 valuation inputs (discount rates ranging from 9.60% to 28.60%) given the lack of active market quotations for the entire portfolio.
• Liquidity Utilization: Monitor the utilization of the new $100 million credit facility and its impact on leverage ratios and net investment income.
• Dividend Sustainability: Assess whether the $0.34 quarterly dividend is fully covered by net investment income or if it requires a return of capital, given the tax character of distributions.